About Us

We discover and drive innovative solutions to bring lifesaving treatments to patients around the world.

Our Company Values

We work with our clients as a trusted partner and critical friend. Hence our name, Symmetron, from the Greek sym (together) and metron (calculate).

Since 2008, we have been growing steadily in size and capability into a highly-respected source of research in health economics and health outcomes.

Integrity

We act in the interest of science and health.

Client Satisfaction

We deliver outstanding products that create value for our clients.

Authenticity

We remain true to ourselves while respecting the diverse personalities and perspectives of others.

Continuous learning

We passionately pursue opportunities to expand and improve our knowledge, skills, and strengths.

Teamwork

We trust, challenge, support and rely on each other to find the best solutions to any problem.

Our Expertise

Neurology & mental health

Dermatology

Cardiometabolic health

Arthritis and immunology

Neurology & mental health

Dermatology

Cardiometabolic health

Arthritis and immunology

Who we are

Meet the team

Alex Diamantopoulos, MSc

Seasoned business leader, entrepreneur and modelling expert with an outstanding track record of launching blockbuster pharmaceuticals.

Managing Director

View Profile

Laura Sawyer, MSc

Accomplished health technology analyst with deep knowledge of evidentiary and regulatory requirements who specializes in solving complex challenges.

Scientific Director

View Profile

Claudia Rinciog, MSc

Solution-focused health economist with extensive experience leading economic analyses and delivering client projects smoothly and efficiently.

Associate Director in Health Economics

View Profile

Bryony Langford, MPhil MSc

A statistician by training, Bryony is skilled at generating and synthesising evidence to inform economic models, HTA submissions and market access materials.

Associate Director in Health Outcomes

View Profile

Vicki Pollit, MSc

As an Associate Director, Vicki is passionate about the scoping and production of high-quality health economics deliverables.

Associate Director

View Profile

Recent Activity

Success Stories

View all

Rare diseases

Gaining reimbursement for a drug targeting a rare disease

Cardiometabolic health

Evaluating the cost-effectiveness of a diagnostic device

Respiratory

Modelling survival after the clinical trials have ended

Dermatology

Validating comparisons of disease treatments in the absence of head-to-head trials

Policy and methods

Developing a framework for analysing the impact of patient-centred outcomes for achieving reimbursement in the UK

Oncology

Overcoming limited evidence to gain reimbursement for a blockbuster oncology drug

Neurology & mental health

Evaluating the cost-effectiveness of a medical device

Dermatology

Overcoming the short-term bias in clinical evidence to compare long-term efficacy of psoriasis treatments

Join our team

Open Opportunities

This is a testimonial. This is a testimonial. This is a testimonial. This is a testimonial. This is a testimonial.